ACB Aurora Cannabis Inc

$-0.40 (-9.09%)

ACB Stock Analysis Overview

What this means: InvestorsObserver gives Aurora Cannabis Inc (ACB) an overall rank of 37, which is below average. Aurora Cannabis Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Aurora Cannabis Inc (ACB) Analyst Forecast

Next 12 months ➝MEAN$9.59+139.70%HIGH$13.54+238.50%LOW$5.16+29.00%Current Price$4.0052-week High$47.2852-week Low$3.93
  • Last Price$4.00
  • Previous Close$4.40
  • Change $-0.40
  • Open$4.36
  • Volume12,445,010
  • Avg. Volume (100-day)6,397,190
  • Market Capitalization$486M
  • Days Range $3.98 - $4.40
  • 52-week Range $3.93 - $47.28
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-0.07
  • Earnings Date11/12/2020
  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec.
  • Beta0.168
  • PEG Ratio
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.